February 2, 2026 Northern Finland Birth Cohort 1966 Begins 60-Year Follow-Up Study on Health and Aging
February 2, 2026 Sacituzumab Govitecan + Pembrolizumab: New Therapy for Advanced Triple‑Negative Breast Cancer
